Alliance Pharma Grows In US With Amberen Menopause Supplement
UK-based Alliance Pharma has strengthened its US offering by acquiring Biogix and its Amberen menopause supplement.
You may also be interested in...
UK-based Alliance Pharma is in talks to expand its burgeoning US consumer health offering with a bolt on acquisition.
UK-based Alliance Pharma saw sales rise double-digits in 2021, with acquisitions bolstering the performance of its established brands. Going into 2022, the company says it is in a strong position to pursue M&A in the consumer health space.
Round-up of Q2 and H1 financial results from three Europe-based consumer health companies: Alliance Pharma, Ipsen and Boiron.